Ad Scientiam is proud to announce the inclusion of the first patient at the Rouen CRCM in the clinical validation study of MuCopilot, our innovative remote monitoring solution for patients living with cystic fibrosis.
Developed in collaboration with the Société Française de la Mucoviscidose and other partners, MuCopilot allows patients to perform tests at home using their smartphones while staying connected with their healthcare teams.

Download the press kit.